Cognizant growth outlook appears healthy, says Oppenheimer After meeting with Cognizant's management, Oppenheimer believes that the discount in the company's stock related to immigration reform is overdone. The firm thinks the company is benefiting from strength in the banking and insurance sectors, as well as projects related to healthcare reform. Oppenheimer reiterates an Outperform rating on the shares.
News For CTSH From The Last 14 Days
Check below for free stories on CTSH the last two weeks.
Cognizant volatility at historic lows as shares near record high Cognizant December and January call option implied volatility is at 20, April is at 25; below its 26-week average of 33 according to Track Data, suggesting deceasing price risk.